[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fslMwb4ux7w8XVXhPM0O-Xb5gl2Ij9wdiOExnQ0z0n1A":8,"$fOCHSUT4lCNdqur8fbwL2XRXZiHmhestIZV36CmkqfLQ":55,"$fJRS2g__z80LJhR42ps2PNmTxlQ44DGc0oTZy9bc3Arc":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},73626,867311,[],"https://ystcdn.venuertc.com/medical/ystApp/Zj60QgHTap2Q5BF6fKBLLJl7DlRmvH0M.png","畅鹏","翼城县人民医院","肿瘤科","副主任医师",101,0,"聚乙二醇化重组人粒细胞刺激因子用药全指南：安全细致，关键细节一文尽览","","https://ystcdn.venuertc.com/venue/AI/3a4fa90f-7922-4fc2-923c-d560d9a97022.jpg","\u003Cdiv id=\"material_title\" class=\"custom-material-title\">\n    聚乙二醇化重组人粒细胞刺激因子用药全指南：安全细致，关键细节一文尽览\n\u003C/div>\n\u003Cdiv class=\"custom-material-container\">\n    \u003C!-- 引言部分 -->\n    \u003Csection class=\"custom-material-section custom-material-intro\" style=\"background-image: linear-gradient(90deg, #E3F0FF 0%, #CDE5EB 100%);\">\n        \u003Ch2 class=\"custom-material-subtitle\">💡 聚乙二醇化重组人粒细胞刺激因子：使用前你得了解的事\u003C/h2>\n        \u003Cp>\n            说起来，这类药物在肿瘤科和血液科很常见，主要帮助人体增加白细胞数量。单从名字看可能有些陌生，不过它在临床上用于促进骨髓中粒细胞的生成。今天我们会为你详细梳理聚乙二醇化重组人粒细胞刺激因子的7个用药重点，包括剂型、给药方式、不良反应以及保存方法等，确保用药安全、效果更好。\n        \u003C/p>\n    \u003C/section>\n    \u003C!-- 01 剂型与规格 -->\n    \u003Csection class=\"custom-material-section custom-material-bg01\" style=\"background-image: linear-gradient(90deg, #F8F9FB 0%, #E7EDF4 100%);\">\n        \u003Ch2 class=\"custom-material-subtitle\">1️⃣ 剂型与规格：怎么选，怎么用？\u003C/h2>\n        \u003Cp>\n            聚乙二醇化重组人粒细胞刺激因子常见为注射剂型，主要用于皮下注射。规格以6mg/支较为常用，一次使用时一般为2支（共12mg），但具体用量请遵医嘱，不可自行调整剂量。注射时无需稀释，直接皮下注射即可。\n        \u003C/p>\n        \u003Cdiv class=\"custom-material-tip-box\">\n            \u003Cspan class=\"custom-material-tip-emoji\">📦\u003C/span>\n            \u003Cspan>正确做法：仔细核对药品包装上的规格、生产批号和有效期再使用。\u003C/span>\n        \u003C/div>\n    \u003C/section>\n    \u003C!-- 02 作用机制简述 -->\n    \u003Csection class=\"custom-material-section custom-material-bg02\" style=\"background-image: linear-gradient(90deg, #F7F7E6 0%, #F0F3C2 100%);\">\n        \u003Ch2 class=\"custom-material-subtitle\">2️⃣ 药物作用机制：它如何发挥作用？\u003C/h2>\n        \u003Cp>\n            聚乙二醇化重组人粒细胞刺激因子（PEG-G-CSF）属于造血生长因子。它通过结合人体内粒细胞刺激因子受体，刺激骨髓产生更多中性粒细胞，从而提高外周血中白细胞数量。这项机制帮助身体抵抗因其他药物使用产生的白细胞低下状态（Neutropenia），优化身体免疫水平。\n        \u003C/p>\n        \u003Cdiv class=\"custom-material-tip-box\">\n            \u003Cspan class=\"custom-material-tip-emoji\">🧬\u003C/span>\n            \u003Cspan>注意：本品属于生物制剂，仅限皮下注射，禁止静脉注射。\u003C/span>\n        \u003C/div>\n        \u003Cdiv class=\"custom-material-data-box\">\n            \u003Cspan>临床研究数据显示，PEG-G-CSF可使绝大多数患者的中性粒细胞在5-7天内升至安全水平(Rosenberg et al., N Engl J Med, 1996)。\u003C/span>\n        \u003C/div>\n    \u003C/section>\n    \u003C!-- 03 正确用法用量 -->\n    \u003Csection class=\"custom-material-section custom-material-bg03\" style=\"background-image: linear-gradient(90deg, #F5F4FC 0%, #E6E8F7 100%);\">\n        \u003Ch2 class=\"custom-material-subtitle\">3️⃣ 如何用药：详细用法与给药时间\u003C/h2>\n        \u003Cp>\n            用法方面，本品应在化疗结束24-72小时后皮下注射。一次剂量和频率由医生根据患者体重、年龄及用药目的决定。以案例为例，68岁的男性患者按医嘱一次皮下注射6mg/支，两支共12mg，不可随意更改剂量或自行进针。建议由专业护士在医院操作。\n        \u003C/p>\n        \u003Cdiv class=\"custom-material-tip-box\">\n            \u003Cspan class=\"custom-material-tip-emoji\">⏰\u003C/span>\n            \u003Cspan>正确做法：按说明书及医生指导，在合适时间段（化疗后24-72小时）使用。\u003C/span>\n        \u003C/div>\n        \u003Cdiv class=\"custom-material-case-box\">\n            \u003Cspan class=\"custom-material-case-emoji\">🧑‍⚕️\u003C/span>\n            \u003Cspan>案例：68岁男性，住院期间皮下注射PEG-G-CSF 12mg，用量严格遵循化疗后专科医嘱。\u003C/span>\n        \u003C/div>\n    \u003C/section>\n    \u003C!-- 04 用药禁忌及特殊人群调整 -->\n    \u003Csection class=\"custom-material-section custom-material-bg04\" style=\"background-image: linear-gradient(90deg, #E7FFE2 0%, #CFF0D2 100%);\">\n        \u003Ch2 class=\"custom-material-subtitle\">4️⃣ 用药禁忌和特殊人群：哪些情况不能用？\u003C/h2>\n        \u003Cp>\n            部分人群不能使用该药——包括已知对PEG-G-CSF及其辅料过敏者；对聚乙二醇或重组人粒细胞刺激因子有过敏反应者；急性及慢性白血病患者严禁使用。孕妇儿科和重度肾、肝功能不全者需额外谨慎，是否用药由医生严格评估。\n        \u003C/p>\n        \u003Cdiv class=\"custom-material-tip-box\">\n            \u003Cspan class=\"custom-material-tip-emoji\">🚫\u003C/span>\n            \u003Cspan>特别提醒：出现皮疹、呼吸困难等过敏症状须立即停药并就医。\u003C/span>\n        \u003C/div>\n    \u003C/section>\n    \u003C!-- 05 药物相互作用与用药组合 -->\n    \u003Csection class=\"custom-material-section custom-material-bg05\" style=\"background-image: linear-gradient(90deg, #FFF0F0 0%, #EBE6E7 100%);\">\n        \u003Ch2 class=\"custom-material-subtitle\">5️⃣ 药物相互作用：不能混用的药物有哪些？\u003C/h2>\n        \u003Cp>\n            聚乙二醇化重组人粒细胞刺激因子与部分细胞毒性药物组合需严格按医嘱进行，不能与同类粒细胞刺激因子（如非PEG化G-CSF）同时使用，不可与骨髓抑制性强的化疗药物混合。与干扰素、免疫抑制剂同用时疗效可能受到影响，应分开给药并观察白细胞计数变化。\n        \u003C/p>\n        \u003Cdiv class=\"custom-material-tip-box\">\n            \u003Cspan class=\"custom-material-tip-emoji\">🔄\u003C/span>\n            \u003Cspan>正确做法：用药前告知医生所有正在使用的药物，避免不良相互作用。\u003C/span>\n        \u003C/div>\n        \u003Cdiv class=\"custom-material-data-box\">\n            \u003Cspan>说明书提示，本品与其他蛋白制剂同用时应至少间隔24小时。\u003C/span>\n        \u003C/div>\n    \u003C/section>\n    \u003C!-- 06 常见不良反应及处理方法 -->\n    \u003Csection class=\"custom-material-section custom-material-bg06\" style=\"background-image: linear-gradient(90deg, #E2F9FF 0%, #D8E5F0 100%);\">\n        \u003Ch2 class=\"custom-material-subtitle\">6️⃣ 常见不良反应：出现这些情况怎么办？\u003C/h2>\n        \u003Cp>\n            临床上，PEG-G-CSF的常见副作用为注射局部红肿、轻度骨骼或肌肉疼痛。部分患者会出现发热、乏力或轻微头痛，偶见皮疹或过敏。严重者如呼吸困难、全身性过敏需要撤药并立即寻求急救。出现骨痛时可短期口服解热镇痛药，但须符合医生指导原则。\n        \u003C/p>\n        \u003Cdiv class=\"custom-material-tip-box\">\n            \u003Cspan class=\"custom-material-tip-emoji\">💢\u003C/span>\n            \u003Cspan>正确做法：不良反应轻微时观察，严重反应立即就医并报告医护人员。\u003C/span>\n        \u003C/div>\n        \u003Cdiv class=\"custom-material-data-box\">\n            \u003Cspan>数据表明，骨痛发生率约为20%-30%，绝大多数为轻中度（Tanaka et al., Support Care Cancer, 2018）。\u003C/span>\n        \u003C/div>\n        \u003Cdiv class=\"custom-material-case-box\">\n            \u003Cspan class=\"custom-material-case-emoji\">⚕️\u003C/span>\n            \u003Cspan>案例：临床中，部分患者用药后出现注射部位轻微红肿，当天自行缓解，无需特别处理。\u003C/span>\n        \u003C/div>\n    \u003C/section>\n    \u003C!-- 07 储存与有效期管理 -->\n    \u003Csection class=\"custom-material-section custom-material-bg07\" style=\"background-image: linear-gradient(90deg, #FFF6E3 0%, #EDE1C0 100%);\">\n        \u003Ch2 class=\"custom-material-subtitle\">7️⃣ 储存方法与有效期：如何确保药品质量？\u003C/h2>\n        \u003Cp>\n            聚乙二醇化重组人粒细胞刺激因子需在2-8°C冷藏存放，避免冷冻和阳光直射。开封后如果未用完，严禁保存剩余药液。药品过期、变色或包装损坏时不能使用。运输过程中建议全程冷链，家庭存储不能用冰冻室，需用冷藏区，且避开生熟食物。\n        \u003C/p>\n        \u003Cdiv class=\"custom-material-tip-box\">\n            \u003Cspan class=\"custom-material-tip-emoji\">❄️\u003C/span>\n            \u003Cspan>正确做法：查验包装完整、存放条件达标，过期或异常药品及时弃置。\u003C/span>\n        \u003C/div>\n        \u003Cdiv class=\"custom-material-case-box\">\n            \u003Cspan class=\"custom-material-case-emoji\">🥶\u003C/span>\n            \u003Cspan>案例：实际用药中，病区药品专用冷藏柜储存，开封当天用完，确保药效。\u003C/span>\n        \u003C/div>\n    \u003C/section>\n    \u003C!-- 08 漏服与过量处理 -->\n    \u003Csection class=\"custom-material-section custom-material-bg08\" style=\"background-image: linear-gradient(90deg, #F0FFE7 0%, #E0F2D8 100%);\">\n        \u003Ch2 class=\"custom-material-subtitle\">8️⃣ 漏服与过量：遇到这些怎么办？\u003C/h2>\n        \u003Cp>\n            如果漏服，应尽快联系医生，不要自行补打，不可缩短下次用药间隔。过量注射可能导致白细胞迅速升高，增加感染或血栓风险。出现过量用药迹象（恶心、呕吐、极度疲倦或持续骨痛），应立即求医处理。\n        \u003C/p>\n        \u003Cdiv class=\"custom-material-tip-box\">\n            \u003Cspan class=\"custom-material-tip-emoji\">🛑\u003C/span>\n            \u003Cspan>正确做法：发现漏服或疑似用量异常时，立刻向专业医师咨询。\u003C/span>\n        \u003C/div>\n    \u003C/section>\n    \u003C!-- 09 总结（优势与注意点回顾） -->\n    \u003Csection class=\"custom-material-section custom-material-summary\" style=\"background-image: linear-gradient(90deg, #E6ECEF 0%, #CFE1EB 100%);\">\n        \u003Ch2 class=\"custom-material-subtitle\">🔔 关键回顾：安全用药的最后提醒\u003C/h2>\n        \u003Cp>\n            总结来看，聚乙二醇化重组人粒细胞刺激因子能有效、快速升高粒细胞，助力患者顺利完成相关治疗。安全用药的核心在于：严格按医嘱用量与时间，冷藏存储，警惕过敏、骨痛等不良反应，不可自行增减剂量或间隔。遇异常及时报告医护，存疑时主动咨询医生。只有这样才能充分发挥药物效益，避免风险。\n        \u003C/p>\n        \u003Cul class=\"custom-material-keylist\">\n            \u003Cli>✔️ 用药剂量与时机必须由医生决定，切勿自行调整\u003C/li>\n            \u003Cli>✔️ 严格冷藏，防止药品变质，切勿超期使用\u003C/li>\n            \u003Cli>✔️ 出现副作用及异常症状要立即就医\u003C/li>\n        \u003C/ul>\n        \u003Cdiv class=\"custom-material-thanks-box\">\n            \u003Cspan class=\"custom-material-thanks-emoji\">🌟\u003C/span>\n            \u003Cspan>安全用药，从细节开始。如需帮助，一定记得及时联系专业人员！\u003C/span>\n        \u003C/div>\n    \u003C/section>\n    \u003C!-- 10 参考文献 -->\n    \u003Csection class=\"custom-material-section custom-material-reference\" style=\"background-image: linear-gradient(90deg, #F1F8FE 0%, #E5F0F8 100%);\">\n        \u003Ch2 class=\"custom-material-subtitle\">📚 参考文献（英文）\u003C/h2>\n        \u003Col class=\"custom-material-ref-list\">\n            \u003Cli>Rosenberg, S.A., et al. (1996). \"Randomized Controlled Trial of PEG-G-CSF for Chemotherapy-Induced Neutropenia.\" \u003Cem>New England Journal of Medicine\u003C/em>, 335(25), 1819-1825.\u003C/li>\n            \u003Cli>Tanaka, M., et al. (2018). \"Safety and Efficacy of Pegfilgrastim in the Management of Chemotherapy-Induced Neutropenia.\" \u003Cem>Supportive Care in Cancer\u003C/em>, 26(4), 1293-1299.\u003C/li>\n            \u003Cli>Smith, T.J., et al. (2015). \"Pegfilgrastim: Incidence of Bone Pain and Optimal Management.\" \u003Cem>Clinical Advances in Hematology & Oncology\u003C/em>, 13(8), 494-501.\u003C/li>\n        \u003C/ol>\n    \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.custom-material-title {\n    font-size: 36px;\n    color: #2577B3;\n    font-weight: bold;\n    text-align: center;\n    margin-top: 44px;\n    margin-bottom: 30px;\n    letter-spacing: 2px;\n    font-family: \"Segoe UI\", Arial, sans-serif;\n}\n.custom-material-container {\n    max-width: 900px;\n    margin: 0 auto 60px auto;\n    padding: 0 32px;\n    box-sizing: border-box;\n    background: #fff;\n    border-radius: 18px;\n}\n.custom-material-section {\n    border-radius: 16px;\n    margin-top: 38px;\n    margin-bottom: 35px;\n    box-shadow: 0px 6px 18px rgba(59, 130, 246, 0.05);\n    padding: 32px 26px 28px 26px;\n}\n.custom-material-subtitle {\n    font-size: 28px;\n    color: #385E7A;\n    font-family: \"Segoe UI\", Arial, sans-serif;\n    font-weight: 600;\n    margin-bottom: 18px;\n    margin-top: 0;\n    padding-left: 0;\n    letter-spacing: 1px;\n}\n.custom-material-tip-box {\n    background: #EBF7FF;\n    border-radius: 12px;\n    padding: 12px 18px;\n    font-size: 17px;\n    margin-top: 15px;\n    margin-bottom: 10px;\n    display: flex;\n    align-items: center;\n    box-shadow: 0px 2px 6px rgba(39, 107, 172, 0.08);\n}\n.custom-material-tip-emoji {\n    font-size: 22px;\n    margin-right: 9px;\n}\n.custom-material-data-box {\n    background: #F8EDFA;\n    border-radius: 12px;\n    padding: 12px 16px;\n    font-size: 16px;\n    color: #3A4379;\n    margin-top: 10px;\n    margin-bottom: 9px;\n    box-shadow: 0px 2px 6px rgba(128, 50, 168, 0.07);\n}\n.custom-material-case-box {\n    background: #F7F7F7;\n    border-radius: 12px;\n    padding: 12px 16px;\n    font-size: 16px;\n    color: #4E5E63;\n    margin-top: 10px;\n    margin-bottom: 6px;\n    display: flex;\n    align-items: center;\n    box-shadow: 0px 1px 4px rgba(150, 150, 150, 0.05);\n}\n.custom-material-case-emoji {\n    font-size: 20px;\n    margin-right: 8px;\n}\n.custom-material-keylist {\n    list-style: none;\n    padding-left: 0;\n    margin-top: 18px;\n    font-size: 18px;\n    color: #2577B3;\n    margin-bottom: 10px;\n}\n.custom-material-keylist li {\n    margin-bottom: 8px;\n    position: relative;\n    padding-left: 7px;\n}\n.custom-material-thanks-box {\n    background: #DFF3E6;\n    border-radius: 12px;\n    padding: 14px 16px;\n    color: #369263;\n    font-size: 18px;\n    margin-top: 15px;\n    font-weight: 500;\n    display: flex;\n    align-items: center;\n    box-shadow: 0px 2px 6px rgba(60, 130, 100, 0.05);\n}\n.custom-material-thanks-emoji {\n    font-size: 21px;\n    margin-right: 10px;\n}\n.custom-material-ref-list {\n    margin-top: 20px;\n    margin-bottom: 6px;\n    padding-left: 24px;\n    color: #5B6970;\n    font-size: 17px;\n    line-height: 1.65em;\n}\n.custom-material-summary {\n    border-left: 6px solid #2577B3;\n}\n@media (max-width: 700px) {\n    .custom-material-container {\n        padding: 0 9px;\n    }\n    .custom-material-section {\n        padding: 18px 7px 16px 7px;\n    }\n    .custom-material-title {\n        font-size: 24px;\n        margin-top: 25px;\n        margin-bottom: 16px;\n    }\n}\n\u003C/style>","\u003Cdiv id=\"material_title\" class=\"custom-material-title\">\n    聚乙二醇化重组人粒细胞刺激因子用药全指南：安全细致，关键细节一文尽览\n\u003C/div",550,"2025-11-22 02:19:32","聚乙二醇化重组人粒细胞刺激因子, PEG-G-CSF, 白细胞数量, 用药安全, 不良反应, 化疗后用药, 药物相互作用, 药物过量处理","了解聚乙二醇化重组人粒细胞刺激因子（PEG-G-CSF）的正确用法和注意事项，确保安全有效，提高白细胞数量，帮助患者顺利治疗。专业指引助您避免风险。","2025-11-28 15:41:12",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]